Charles Brynelsen insider trades
Open-market stock purchases and sales by Charles Brynelsen, Director at Envoy Medical, Inc, from SEC Form 4 filings since Jul 24, 2017.
Track record: 0% of 3 scored buys are up 5% or more since purchase, averaging -60%.